Organoids have emerged as a revolutionary model in biomedical research and clinical applications, offering a more accurate representation of human tissues and organs compared to traditional models. This review provides a comprehensive overview of the current landscape of organoid technology, highlighting its transformative impact across various fields, including oncology, toxicology, drug discovery, and personalized medicine. Organoids, derived from stem cells, mimic the architecture and function of native organs, enabling more reliable drug screening, disease modeling, and therapeutic testing. The integration of synthetic biology, artificial intelligence, and automation has further expanded the capabilities of organoids, enhancing their role in personalized medicine and high-throughput drug screening. The history of organoid research dates back to the early 20th century, with significant advancements in the 2000s, particularly with the development of induced pluripotent stem cells (iPSCs). Organoids have been successfully applied to various organ systems, including the pancreas, liver, brain, and heart, providing insights into disease mechanisms and therapeutic strategies. In oncology, organoids have proven valuable in understanding tumor biology, drug resistance, and immunotherapy. They offer a more accurate model for predicting patient responses to treatments and have been used in clinical trials to test new therapies. The use of patient-derived organoids allows for personalized medicine, enabling tailored treatment plans based on individual genetic and physiological characteristics. Organoids also play a crucial role in toxicology research, providing a platform for assessing the effects of environmental toxins and drug-induced toxicity. The integration of organoids with synthetic biology and advanced technologies has opened new avenues for drug development, disease modeling, and therapeutic innovation. As organoid technology continues to evolve, it holds great promise for revolutionizing biomedical research and clinical practice, offering more effective and personalized treatment options for patients.Organoids have emerged as a revolutionary model in biomedical research and clinical applications, offering a more accurate representation of human tissues and organs compared to traditional models. This review provides a comprehensive overview of the current landscape of organoid technology, highlighting its transformative impact across various fields, including oncology, toxicology, drug discovery, and personalized medicine. Organoids, derived from stem cells, mimic the architecture and function of native organs, enabling more reliable drug screening, disease modeling, and therapeutic testing. The integration of synthetic biology, artificial intelligence, and automation has further expanded the capabilities of organoids, enhancing their role in personalized medicine and high-throughput drug screening. The history of organoid research dates back to the early 20th century, with significant advancements in the 2000s, particularly with the development of induced pluripotent stem cells (iPSCs). Organoids have been successfully applied to various organ systems, including the pancreas, liver, brain, and heart, providing insights into disease mechanisms and therapeutic strategies. In oncology, organoids have proven valuable in understanding tumor biology, drug resistance, and immunotherapy. They offer a more accurate model for predicting patient responses to treatments and have been used in clinical trials to test new therapies. The use of patient-derived organoids allows for personalized medicine, enabling tailored treatment plans based on individual genetic and physiological characteristics. Organoids also play a crucial role in toxicology research, providing a platform for assessing the effects of environmental toxins and drug-induced toxicity. The integration of organoids with synthetic biology and advanced technologies has opened new avenues for drug development, disease modeling, and therapeutic innovation. As organoid technology continues to evolve, it holds great promise for revolutionizing biomedical research and clinical practice, offering more effective and personalized treatment options for patients.